Screening technology augmented

Together with the syngo Opdima biopsy unit, where the patient is in a sitting position, Siemens now claims to offer a comprehensive biopsy portfolio with MammoTest. This provides the physician with the choice of two stereotactic systems. The ergonomically designed table ensures examinations as comfortable as possible for the patient.

Siemens acquired the rights to the MammoTest system last summer from Fischer Imaging. The technology enables 360° access to lesions. In addition, biopsies can be performed more accurately using Polar Coordinate Targeting and a high resolution CCD (charged coupled device) camera. This improves workflow while reducing the examination time.

Syngo Opdima is already the gold standard of digital biopsy and detailed imaging. It is designed for fast, efficient needle and core biopsies and for localisation. With a detector resolution of 20 Lp/mm (line pairs per millimeter), syngo Opdima exceeds all comparable systems. The system is compatible with most of the mammography products of the Siemens MAMMOMAT range, including the MAMMOMAT Novation digital full field system.

Jochen Dick, head of the special systems product group at Siemens Medical Solutions said: “Siemens can now offer maximum flexibility in its biopsy solutions. With this new technology, we can now offer physicians a solution that best fits their needs – either the syngo Opdima system or the MammoTest as a table system for the prone position.”